SMTL ID : 5i8a.1

TrkA with (6~{R})-3-methylsulfanyl-6-phenyl-1-(1~{H}-pyrazol-3-yl)-6,7-dihydro-5~{H}-thieno[3,4-c]pyridin-4-one

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

1 x 69C: (6R)-3-(methylsulfanyl)-6-phenyl-1-(1H-pyrazol-3-yl)-6,7-dihydrothieno[3,4-c]pyridin-4(5H)-one(Non-covalent)

69C.1: 14 residues within 4Å: Chain A: L.19, G.20, E.21, V.27, A.45, E.93, Y.94, M.95, R.96, G.98, L.160, D.171, S.175, R.176 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.19, A:V.27, A:A.45, A:L.160, A:R.176 Hydrogen bonds: A:E.93, A:M.95, A:R.176, A:R.176 Water bridges: A:D.99

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 2 residues within 4Å: Chain A: A.261, R.264 Ligand excluded by PLIP

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.3: 3 residues within 4Å: Chain A: R.152, R.205, F.207 4 PLIP interactions: 4 interactions with chain A Water bridges: A:R.205, A:F.207 Salt bridges: A:R.152, A:R.205 ACT.4: 4 residues within 4Å: Chain A: R.105, K.228, Q.229, Y.232 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Q.229, A:Y.232 Hydrogen bonds: A:Q.229 Salt bridges: A:R.105 ACT.5: 6 residues within 4Å: Chain A: W.221, T.225, K.228, Y.232, E.250, P.252 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.232 Hydrogen bonds: A:Y.232 Salt bridges: A:K.228

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Greshock, T.J. et al., Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors. Bioorg. Med. Chem. Lett. (2016)

Release Date

2017-08-09

Peptides

High affinity nerve growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

High affinity nerve growth factor receptor